Cargando…

High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients

OBJECTIVE: To evaluate B-cell- and T-cell-mediated immune response to SARS-CoV-2 mRNA vaccination in patients with complex or rare systemic autoimmune diseases previously been treated with or under continuous treatment with B-cell-targeted therapies including rituximab (RTX) and belimumab (BEL). MAT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fabris, Martina, De Marchi, Ginevra, Domenis, Rossana, Caponnetto, Federica, Guella, Silvia, Dal Secco, Chiara, Cabas, Nicola, De Vita, Salvatore, Beltrami, Antonio Paolo, Curcio, Francesco, Quartuccio, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995326/ https://www.ncbi.nlm.nih.gov/pubmed/35427999 http://dx.doi.org/10.1016/j.jaut.2022.102827

Ejemplares similares

Humoral and T-Cell Mediated Response after the Third Dose of mRNA Vaccines in Patients with Systemic Lupus Erythematosus on Belimumab
por: Quartuccio, Luca, et al.
Publicado: (2023)

Comment on: “SARS CoV-2 vaccine AND rituximab, timing is probably a key for a better vaccine response” by Verhoeven et al. Joint Bone Spine 2021;88:105258
por: De Marchi, Ginevra, et al.
Publicado: (2022)

Controversies on Rituximab Therapy in Sjögren Syndrome-Associated Lymphoproliferation
por: Quartuccio, Luca, et al.
Publicado: (2009)

Resistance to Rituximab Therapy and Local BAFF Overexpression in Sjögren’s Syndrome-Related Myoepithelial Sialadenitis and Low-Grade Parotid B-Cell Lymphoma
por: Quartuccio, Luca, et al.
Publicado: (2008)

Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia
por: Quartuccio, Luca, et al.
Publicado: (2021)

Serum levels of anti-CCP antibodies, anti-MCV antibodies and RF IgA in the follow-up of patients with rheumatoid arthritis treated with rituximab
por: Fabris, Martina, et al.
Publicado: (2010)

A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren’s syndrome
por: Mariette, Xavier, et al.
Publicado: (2022)

Pro-Inflammatory Microenvironment Modulates the Transfer of Mutated TP53 Mediated by Tumor Exosomes
por: Domenis, Rossana, et al.
Publicado: (2021)

Risk of Cancer in Connective Tissue Diseases in Northeastern Italy over 15 Years
por: Treppo, Elena, et al.
Publicado: (2022)

Circulating exosomes express α(4)β(7) integrin and compete with CD4+ T cells for the binding to Vedolizumab
por: Domenis, Rossana, et al.
Publicado: (2020)

Predictive Factors of the Use of Rituximab and Belimumab in Spanish Lupus Patients
por: Capdevila, O., et al.
Publicado: (2023)

Rituximab Induction and Maintenance in ANCA-Associated Vasculitis: State of the Art and Future Perspectives
por: Treppo, Elena, et al.
Publicado: (2021)

The Safety and Efficacy of Rituximab and Belimumab in Systemic Lupus Erythematosus: A Systematic Review
por: Abid, Naushad, et al.
Publicado: (2023)

A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE
por: van Dam, Laura S, et al.
Publicado: (2020)

Toll-like Receptor-4 Activation Boosts the Immunosuppressive Properties of Tumor Cells-derived Exosomes
por: Domenis, Rossana, et al.
Publicado: (2019)

Characterization of the Proinflammatory Profile of Synovial Fluid-Derived Exosomes of Patients with Osteoarthritis
por: Domenis, Rossana, et al.
Publicado: (2017)

Letter in reply: Crusted scabies mimicking a lupus flare after rituximab and belimumab
por: Androsov, Grigoriy, et al.
Publicado: (2021)

Cytokines from Bench to Bedside: A Retrospective Study Identifies a Definite Panel of Biomarkers to Early Assess the Risk of Negative Outcome in COVID-19 Patients
por: Fabris, Martina, et al.
Publicado: (2022)

The Influence of a Stressful Microenvironment on Tumor Exosomes: A Focus on the DNA Cargo
por: Domenis, Rossana, et al.
Publicado: (2020)

Belimumab and Rituximab in Systemic Lupus Erythematosus: A Tale of Two B Cell-Targeting Agents
por: Wise, Leanna M., et al.
Publicado: (2020)

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis
por: Atisha‐Fregoso, Yemil, et al.
Publicado: (2020)

Systemic T Cells Immunosuppression of Glioma Stem Cell-Derived Exosomes Is Mediated by Monocytic Myeloid-Derived Suppressor Cells
por: Domenis, Rossana, et al.
Publicado: (2017)

Brain Endothelial Cells Activate Neuroinflammatory Pathways in Response to Early Cerebral Small Vessel Disease (CSVD) Patients’ Plasma
por: Cifù, Adriana, et al.
Publicado: (2023)

Shared Pathogenetic Features Between Common Variable Immunodeficiency and Sjögren’s Syndrome: Clues for a Personalized Medicine
por: Quartuccio, Luca, et al.
Publicado: (2021)

Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS)
por: Zen, Margherita, et al.
Publicado: (2023)

Belimumab use during pregnancy: Interim results of the belimumab pregnancy registry
por: Juliao, Patricia, et al.
Publicado: (2022)

Anti-β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies exert similar pro-thrombotic effects in peripheral blood monocytes and endothelial cells
por: Cifù, A., et al.
Publicado: (2019)

Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care
por: Quartuccio, Luca, et al.
Publicado: (2020)

NKp30 Receptor Upregulation in Salivary Glands of Sjögren’s Syndrome Characterizes Ectopic Lymphoid Structures and Is Restricted by Rituximab Treatment
por: Pontarini, Elena, et al.
Publicado: (2021)

Patient Experiences of Systemic Lupus Erythematosus: Findings From a Systematic Review, Meta‐Summary, and Meta‐Synthesis
por: Petrocchi, Valentina, et al.
Publicado: (2022)

An update on belimumab for the treatment of lupus
por: Thanou-Stavraki, Aikaterini, et al.
Publicado: (2011)

Belimumab in systemic lupus erythematosus
por: Vilas-Boas, Andreia, et al.
Publicado: (2015)

Belimumab in Systemic Lupus Erythematosus
por: Srivastava, Ankita
Publicado: (2016)

Pro inflammatory stimuli enhance the immunosuppressive functions of adipose mesenchymal stem cells-derived exosomes
por: Domenis, Rossana, et al.
Publicado: (2018)

The Exposure to Osteoarthritic Synovial Fluid Enhances the Immunomodulatory Profile of Adipose Mesenchymal Stem Cell Secretome
por: Cifù, Adriana, et al.
Publicado: (2020)

Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies
por: Petricca, Luca, et al.
Publicado: (2020)

A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol
por: McClure, Mark E., et al.
Publicado: (2023)

ADMA as a possible marker of endothelial damage. A study in young asymptomatic patients with cerebral small vessel disease
por: Janes, Francesco, et al.
Publicado: (2019)

Psychological Effects of Lockdown Measures for the COVID-19 Outbreak in Patients with Systemic Lupus Erythematosus
por: Quartuccio, Luca, et al.
Publicado: (2021)

A human neuronal model of Niemann Pick C disease developed from stem cells isolated from patient’s skin
por: Bergamin, Natascha, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_udkqsgod6na21cdmr7grsf32sf